Quest Diagnostics (NYSE: DGX) and Mercy today announced that Quest has completed its previously announced acquisition of the outreach laboratory services business of Mercy in an all-cash asset transaction. Additional financial terms were not disclosed.
With the transaction, Mercy’s outreach laboratory services will transition to Quest’s full-service laboratory in Lenexa, Kansas, and the company’s network of rapid response laboratories across the Midwest. Mercy will continue to wholly own and operate its hospital laboratories for tests connected to inpatient and hospital-based outpatient care needs.
The aim of the transaction is to broaden access to innovative, quality, and cost-effective laboratory services to deliver affordable patient care throughout the Midwest. The acquisition immediately broadens Quest’s reach to providers and patients in Arkansas, Kansas, Missouri, and Oklahoma. Patients and providers will benefit from access to Quest’s innovative, industry-leading test menu, health plan relationships, network of about 1,000 conveniently located patient-access sites in the Great Midwest, and more cost-effective services.
Source: Biospace
Want to publish your own articles on DistilINFO Publications?
Send us an email, we will get in touch with you.
